Sun Pharma gets USFDA approval for new device to treat skin disease
Pharma major Sun Pharmaceutical Industries on Friday said it has received approval from the USFDA for a new…
Pharma major Sun Pharmaceutical Industries on Friday said it has received approval from the USFDA for a new…
Sun Pharmaceutical Industries share price, having gained 56% in the last six months, declined 1.91% in intraday trades…
The company said it would work closely with the US FDA to address the agency's concerns, which the…
Meanwhile, Sun Pharmaceutical Industries has reported a consolidated net profit at ₹2,166 crore for Q3 FY23
Equity benchmark Sensex crashed about 870 points to slip below the 55,000-level in opening deals on Monday